SCFA

What brain concentrations of SCFAs are achieved via oral probiotics and are they

pharmacokinetics | 2026-04-11 | 0 hypotheses

Debate: SCFA Deficiency Drives Microglial Hyperactivation via GPR43/NF-κB Dysreg

closed · Rounds: 4 · Score: 0.13 · 2026-04-27

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

closed · Rounds: 4 · Score: 0.76 · 2026-04-26

Formal debate: TLR4 priming is the actionable driver in: How does gut microbiome

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

Formal debate: plasma LPS-binding protein separates causal from compensatory sta

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

closed · Rounds: 4 · Score: 0.78 · 2026-04-26

Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects

closed · Rounds: 4 · Score: 0.63 · 2026-04-24

The debate highlighted that while SCFAs can cross the blood-brain barrier, the a

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

closed · Rounds: 4 · Score: 0.84 · 2026-04-16

The debate identified a critical mechanistic gap between SCFA production by gut

closed · Rounds: 4 · Score: 0.70 · 2026-04-12

Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-fi

Score: 0.650 · neurodegeneration · 2026-04-24

Low-micromolar systemic SCFA exposure is unlikely to directly drive substantia nigra alpha-synuclein clearance, but colo

NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosis into Chronic IL-1β

Score: 0.620 · neurodegeneration · 2026-04-26

Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing

The most realistic translational use of physiological SCFAs is as an adjunct to

Score: 0.610 · neurodegeneration · 2026-04-24

Physiological SCFA elevation may generate a weak, context-dependent signal that is insufficient alone but could become b

SCFA Deficiency Disrupts Microglial Homeostasis and Promotes Neurodegeneration

Score: 0.583 · neurodegeneration · 2026-04-26

Reduced SCFA-producing bacteria (Lachnospiraceae, Ruminococcaceae, Faecalibacterium) in PD leads to microglial dysfuncti

Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Deficiency into IDO1-Dr

Score: 0.580 · neurodegeneration · 2026-04-26

Aryl hydrocarbon receptor (AhR), expressed in microglia, astrocytes, and neurons, normally ligates tryptophan catabolite

Direct neuronal HDAC inhibition is unlikely to mediate therapeutic alpha-synucle

Score: 0.560 · neurodegeneration · 2026-04-24

The classic butyrate neuroprotection narrative likely depends on pharmacologic exposure sufficient for HDAC inhibition,

Physiological SCFAs may worsen alpha-synuclein pathology through FFAR2/GPR43-NLR

Score: 0.550 · neurodegeneration · 2026-04-24

A key liability hypothesis is that low-range SCFA signaling can be receptor-biased toward inflammasome activation in sus